X-13319786-T-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_001135995.2(ATXN3L):āc.149A>Gā(p.Glu50Gly) variant causes a missense change. The variant allele was found at a frequency of 0.00000911 in 1,098,100 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: not found (cov: 23)
Exomes š: 0.0000091 ( 0 hom. 3 hem. )
Consequence
ATXN3L
NM_001135995.2 missense
NM_001135995.2 missense
Scores
2
4
11
Clinical Significance
Conservation
PhyloP100: 5.50
Genes affected
ATXN3L (HGNC:24173): (ataxin 3 like) This intronless gene may be a pseudogene (PMID:11450850). This gene is similar to the multi-exon gene which encodes ataxin 3 and contains a coding region which could encode a protein similar to ataxin 3. Mutations in the gene encoding ataxin 3 are associated with Machado-Joseph disease. [provided by RefSeq, Sep 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.33780158).
BS2
High Hemizygotes in GnomAdExome4 at 3 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATXN3L | NM_001135995.2 | c.149A>G | p.Glu50Gly | missense_variant | 1/1 | ENST00000380622.5 | NP_001129467.1 | |
ATXN3L | NM_001387036.1 | c.149A>G | p.Glu50Gly | missense_variant | 1/2 | NP_001373965.1 | ||
GS1-600G8.3 | NR_046087.1 | n.2102T>C | non_coding_transcript_exon_variant | 17/17 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATXN3L | ENST00000380622.5 | c.149A>G | p.Glu50Gly | missense_variant | 1/1 | 6 | NM_001135995.2 | ENSP00000369996.2 | ||
GS1-600G8.3 | ENST00000431486.1 | n.2102T>C | non_coding_transcript_exon_variant | 17/17 | 1 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD3 genomes
Cov.:
23
GnomAD3 exomes AF: 0.00000546 AC: 1AN: 183134Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67728
GnomAD3 exomes
AF:
AC:
1
AN:
183134
Hom.:
AF XY:
AC XY:
0
AN XY:
67728
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000911 AC: 10AN: 1098100Hom.: 0 Cov.: 31 AF XY: 0.00000825 AC XY: 3AN XY: 363458
GnomAD4 exome
AF:
AC:
10
AN:
1098100
Hom.:
Cov.:
31
AF XY:
AC XY:
3
AN XY:
363458
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 23
GnomAD4 genome
Cov.:
23
Bravo
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 26, 2024 | The c.149A>G (p.E50G) alteration is located in exon 1 (coding exon 1) of the ATXN3L gene. This alteration results from a A to G substitution at nucleotide position 149, causing the glutamic acid (E) at amino acid position 50 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;.
FATHMM_MKL
Benign
D
LIST_S2
Benign
T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Pathogenic
M;.
PrimateAI
Benign
T
PROVEAN
Pathogenic
D;.
REVEL
Benign
Sift
Uncertain
D;.
Sift4G
Uncertain
D;D
Polyphen
P;.
Vest4
MutPred
Loss of solvent accessibility (P = 0.0387);Loss of solvent accessibility (P = 0.0387);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at